Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. [electronic resource]
- Molecular cancer therapeutics Jul 2004
- 803-12 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.